Siemens Healthineers Academy

Fibroadenolipoma (USA)

Can we avoid biopsies with using tomosynthesis for evaluating benign lesions? 
Typical benign pattern: US, FFDM, IN2D, DBT.

This case was a 21 year old lady who felt a lump of palpable lump in the left breast. We started with ultrasound that showed a circumscribed heterogeneous mass. This could be a fibroadenoma, lipoma, or. It could also be a fibroadenoma. That is why we performed. You know unilateral mammography. Showing. These masks. And on Tomo, clearly. Shows the typical futures of. With a fibroadenoma lipoma with fatty areas inside the mask. So the biopsy is not needed for this palpable mass.

1/1/2022 Basic 3 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spairi SIEMENS . 03_Basic_3, PID3690 Healthineers * 1/1/2022 F PID3690 US Vel PID3690 Frec Gn check S/A 2/1/2022 (Study date) Map Current DR No Image 1 L 4.01 cm ReportFlow BASIC Series Navigator Findings MR Viewing 8:49 PM Printing Tools Clinical information 21-year-old female Palpable lump in the left breast Add Study MG, 2/1/2022 n.a ., 2 months ... Combo TRCC not found. TRMLO/TRML not found. TLMLO Favorite Layouts MR DYN C.US | C .... MR.Dyna ... MR.Empty Slice thickness: 1.00 mm Pathology Fibroadenolipoma MR.Dyna Conclusion DBT shows the typical pattern of a fibrolipoma. No need for a percutaneous puncture. Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. SIEMENS

  • dbt
  • in2d
  • ffdm
  • benign lesions